Anzeige
Mehr »
Samstag, 10.01.2026 - Börsentäglich über 12.000 News
Fundamental stark, Kurs zu niedrig - Chance beim Krebs-Impfstoff-Pionier!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Investing.com

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrParanovus regains compliance with Nasdaq minimum bid price requirement
FrPDS Biotech submits amended protocol for phase 3 cancer trial
FriShares launches new bitcoin ETP on London Stock Exchange
FrOklo stock maintains Outperform rating as Meta nuclear deal boosts outlook
FrUBS reiterates Buy rating on ExxonMobil stock, citing refining strength
FrPiper Sandler raises Acrivon Therapeutics stock price target to $8 on positive cancer data
FrPiper Sandler reiterates Overweight rating on Citi stock
FrUBS raises Aritzia stock price target to C$168 on strong growth outlook
FrPiper Sandler raises NewtekOne stock price target on upbeat 2026 outlook
FrPiper Sandler raises Commerce Bancshares stock price target on FNBT deal
FrServiceNow stock rating reiterated at Underweight by KeyBanc
FrRPM International stock rating reiterated by KeyBanc amid temporary setback
FrKeyBanc reiterates Overweight rating on Dutch Bros stock with $77 target
FrBitmine appoints Young Kim as CFO and COO, adds board seat
FrScienjoy receives 180-day Nasdaq extension to meet minimum bid price
FrClene secures $28 million in registered direct offering for ALS drug
FrPerma-Fix receives permit renewal tripling liquid waste capacity
FrRiley Permian declares quarterly dividend of $0.40 per share
FrSEALSQ and Kaynes SemiCon form joint venture for quantum-resistant chips
FrYoulife forms joint venture with Sealand for cruise talent development
FrCG Oncology accelerates timeline for bladder cancer trial data
FrRoyalty Pharma increases quarterly dividend by 6.8% to $0.235
FrEvolus reports 15% Q4 growth, projects 2026 profitability
FrJefferies raises Cytokinetics stock price target to $90 on ACACIA study
FrDA Davidson lowers Apogee Enterprises stock price target on cost pressures